DGEN — Deltagen Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$0.02m
- $0.77m
Annual cashflow statement for Deltagen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PRESS | PRESS | PRESS | PRESS | PRESS |
| Standards: | — | — | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.84 | -1.17 | -4.42 | 0.156 | -0.046 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.014 | -0.065 | 4.5 | -0.04 | 0 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.693 | 2.29 | -0.088 | -0.177 | 0.07 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.4 | 1.23 | -0.01 | -0.061 | 0.024 |
| Capital Expenditures | 0 | — | 0 | 0 | 0 |
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | 0 | — | 0 | 0 | 0 |
| Financing Cash Flow Items | — | -1.27 | — | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.27 | -2.54 | — | — | 0 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.12 | -1.31 | -0.01 | -0.061 | 0.024 |